Skip to main content
. 2021 Dec 26;22(7):e452–e458. doi: 10.1016/j.clml.2021.12.011

Figure 2.

Figure 2

Clinical COVID-19 outcomes. Hematologic malignancy (HM) cohort (blue) compared to the general population (GP) cohort (orange). For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.